Reliability of the Lymph Node Ratio in the Prediction of Gastric Cancer Survival
暂无分享,去创建一个
[1] A. Senger,et al. Prognostic significance of the metastatic lymph node ratio compared to the TNM classification in stage III gastric cancer , 2021, Nigerian journal of clinical practice.
[2] Jia Wei,et al. Prognostic Nomograms Based on Three Lymph Node Classification Systems for Resected Gastric Adenocarcinoma: A Large Population-Based Cohort Study and External Validation , 2021, Annals of Surgical Oncology.
[3] J. Ajani,et al. Benchmarks for nodal yield and ratio for node-positive gastric cancer. , 2021, Surgery.
[4] B. Badgwell,et al. Current treatment and recent progress in gastric cancer , 2021, CA: a cancer journal for clinicians.
[5] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[6] M. Kanda,et al. Accurate Risk Stratification of Patients with Node-Positive Gastric Cancer by Lymph Node Ratio , 2020, World Journal of Surgery.
[7] H. Hoshi. Management of Gastric Adenocarcinoma for General Surgeons. , 2020, The Surgical clinics of North America.
[8] T. Yoshikawa,et al. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer , 2020, Annals of Surgical Oncology.
[9] S. Cai,et al. Young age increases risk for lymph node positivity in gastric cancer: A Chinese multi-institutional database and US SEER database study , 2020, Journal of Cancer.
[10] G. Yaprak,et al. Prognostic factors for survival in patients with gastric cancer: Single-centre experience , 2019, Northern clinics of Istanbul.
[11] Z-P Tan. Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review , 2019, Medical science monitor : international medical journal of experimental and clinical research.
[12] J. Chen,et al. Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer , 2018, World Journal of Surgical Oncology.
[13] Hui-mian Xu,et al. Development of a risk-scoring system to evaluate the serosal invasion for macroscopic serosal invasion positive gastric cancer patients. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[14] M. Tez,et al. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma , 2018, Acta chirurgica Belgica.
[15] H. Weir,et al. The TNM classification of malignant tumours-towards common understanding and reasonable expectations. , 2017, The Lancet. Oncology.
[16] Ping Li,et al. Differences in the multimodal treatment of gastric cancer: East versus west , 2017, Journal of surgical oncology.
[17] D. Ichikawa,et al. Positive Lymph Node Ratio as an Indicator of Prognosis and Local Tumor Clearance in N3 Gastric Cancer , 2016, Journal of Gastrointestinal Surgery.
[18] P. Coffer,et al. Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor. , 2013, Immunity.
[19] Ji-hoon Kim,et al. Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection , 2013, Gastric Cancer.
[20] F. Sarkar,et al. Microenvironment generated during EGFR targeted killing of pancreatic tumor cells by ATC inhibits myeloid-derived suppressor cells through COX2 and PGE2 dependent pathway , 2013, Journal of Translational Medicine.
[21] H. Lee,et al. Undifferentiated-type gastric adenocarcinoma: prognostic impact of three histological types , 2012, World Journal of Surgical Oncology.
[22] K. Bickenbach,et al. Comparisons of Gastric Cancer Treatments: East vs. West , 2012, Journal of gastric cancer.
[23] Atilla Kurt,et al. Guidelines for Extended Lymphadenectomy in Gastric Cancer: A Prospective Comparative Study , 2012, Annals of Surgical Oncology.
[24] L. Jacks,et al. Comparison of Gastric Cancer Survival Following R0 Resection in the United States and Korea Using an Internationally Validated Nomogram , 2010, Annals of surgery.
[25] Y. Sugiyama,et al. Prognostic Significance of the Metastatic Lymph Node Ratio in Gastric Cancer Patients , 2009, World Journal of Surgery.
[26] Quentin Liu,et al. Positive Lymph Node Ratio Is an Independent Prognostic Factor in Gastric Cancer After D2 Resection Regardless of the Examined Number of Lymph Nodes , 2009, Annals of Surgical Oncology.
[27] S. Mocellin,et al. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[28] S. Fushida,et al. Outcome of ratio of lymph node metastasis in gastric carcinoma , 2002, Annals of Surgical Oncology.
[29] David D. Smith,et al. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] Mitsuru Sasako,et al. Determining prognostic factors for gastric cancer using the regression tree method , 2002, Gastric Cancer.
[31] D. Gouma,et al. Extended lymph-node dissection for gastric cancer. , 1999, The New England journal of medicine.
[32] S. Kim,et al. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer , 1998, Gastric Cancer.